Ratio of Profits to Net Sales
(%)
2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 |
-4.4 | -3.2 | 2.6 | 5.8 | 4.7 |
-4.5 | -1.6 | 3.9 | 6.8 | 6.5 |
-32.8 | -2.9 | 7.0 | 5.8 | 4.5 |
Equity ratio
(%)
Return on equity(ROE)
(%)
Return on assets(ROA)
(%)
Capital expenditure,Depreciation and amortization
(Millions of Yen)
2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 |
1,677 | 1,392 | 2,371 | 2,302 | 1,997 |
2,304 | 1,604 | 1,877 | 1,895 | 1,967 |
Research and development expenses
(Millions of Yen)
(%)
2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 |
4,898 | 4,002 | 4,050 | 3,653 | 3,733 |
6.3 | 5.6 | 4.6 | 3.7 | 3.6 |
Interest-bearing debt
(Millions of Yen)
(times)
2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 |
34 | 11,312 | 11,207 | 10,615 | 10,801 |
0.00 | 0.11 | 0.10 | 0.09 | 0.09 |
Dividend per share and total return ratio
(Yen)
(%)
Cash Flows
(Millions of Yen)
Cash & cash equivalents at end of the period
(Millions of Yen)
The content of this data is based on financial statements.
Although we pay close attention to the conversion of posted data, errors in information may occur due to artificial falsification by a third party, mechanical defects due to equipment failure, etc., or other force majeure. note that. please. For details on financial results, etc., please refer to Financial Results and Timely Disclosure Information.
[Precautions for use]
- If revisions to financial statements, etc. are announced, the content of this data will not be reflected immediately.
- Due to changes in financial statement formats, some measures may be updated only for the full year.